We believe we can do this best by focusing on areas where we have a deep base of experience. So we specialize in serving pharmaceutical and biotech companies, and in this universe, we focus on a short list of business applications that we understand well.
We resist the temptation to try to be all things to all people.
With this specialization and focus, we can help our clients tackle complex challenges, develop strategic and operational plans, and improve the efficiency and effectiveness of their operations.
Today’s pharmaceutical industry faces an unprecedented set of challenges. We believe that success often requires partnership with trusted third parties. Our philosophy is to establish deep, trusting relationships focused on helping our clients improve their business performance by providing support in the areas we know well. We want our clients to think of us as their “Allies for Growth”.
We also apply innovative business practices that allow us to deliver for our clients and keep our costs low. This allows us to price our offerings competitively in the marketplace. We don’t compete on price, per se, but we recognize the times that we are in and believe that our model provides us with competitive advantage.
We appreciate your interest and hope you will use our website to learn more about us. Please contact us directly to discuss ways in which we can work with your organization to help you improve performance.
Michael J. Luby, Founder, President & CEO
Mike Luby is founder of BioPharma Alliance and serves as our President & CEO.
Mike brings 20 years of pharmaceutical marketing and sales experience to this position, including 10 years of experience as a successful entrepreneur.
Prior to founding BioPharma Alliance, Mike co-founded TargetRx, a leading pharmaceutical database and analytics company focused on helping pharmaceutical companies understand the drivers of their sales and marketing efforts. During his ten years at TargetRx, the Company succeeded in raising over $50 million in capital, securing clients in the majority of the top 30 pharmaceutical companies worldwide and delivering over $120 million in revenue on a cumulative basis. Mike is the lead author on TargetRx's patented method of analyzing the effectiveness of marketing strategies. Mike has been honored with the Philadelphia Business Journal's "40 Under 40" award and selected by PharmaVOICE as one of the “100 most inspiring people in life sciences.” Under his leadership, TargetRx has been recognized by the Eastern Technology Council with the Enterprise Award for “Growth Company of the Year.”
Prior to starting TargetRx, Mike spent 10 years at Merck & Co., Inc., where he created and executed marketing strategies for both specialty and mass-market drugs. As head of worldwide marketing for 2 late stage, pre-launch products at Merck, Mike spearheaded global strategy and launch planning. He also served as director of new product marketing, managing the marketing strategy of early-stage drug development candidates and evaluating the potential of in-licensing opportunities from biotech companies. Mike's previous roles included senior marketing manager for Fosamax, marketing analyst for Vasotec and Prilosec, as well as positions focusing on marketing to managed care customers in an assignment at Merck-Medco Managed Care. Mike began his career at Merck in sales.
Mike holds a B.A. in economics from Dartmouth College and an M.B.A. from the Wharton School of the University of Pennsylvania. Mike serves on the Board of Directors of TargetRx. You can contact Mike at firstname.lastname@example.org.